Results 41 to 50 of about 20,046 (138)
Turkish Journal of Family Practice, 2017 Dünyada önlenebilir erken ölüm ve sakatlık nedenlerinin başında sigara kullanımı yer almaktadır. Nikotin replasman tedavisi (NRT), vareniklin ve bupropion HCL başlıca sigara bırakma ilaçlarıdır.
Ruhuşen Kutlu +2 more
doaj +1 more source
Drugs of Today, 2006 Bupropion was initially developed and licensed for the treatment of major depressive disorder in the United States in 1989. It was licensed as a pharmacotherapy for smoking cessation in the United States in 1997 and in the United Kingdom in 2000, and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder ...
europepmc +3 more sources
Frontiers in PharmacologyBackgroundEsketamine, the first Food and Drug Administration-approved fast-acting antidepressant, has limited use because of its addictive properties.
Ying Xiao +9 more
doaj +1 more source
Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
Neurology Research International, 2018 Hesperidin, a well-known flavanone glycoside mostly found in citrus fruits, showed neuroprotective and antidepressant activity. Agomelatine, a melatonergic MT1/MT2 agonist and 5-HT2C receptor antagonist, exhibits good antidepressant efficacy.
Jegan Sakthivel Nadar +4 more
doaj +1 more source
The use of bupropion SR in cigarette smoking cessation
International Journal of COPD, 2008 Scott WilkesDepartment of Primary and Community Care, School of Health, Natural and Social Sciences, University of Sunderland, Sunderland, United KingdomAbstract: Cigarette smoking remains the largest preventable cause of premature death in developed ...
Scott Wilkes
doaj
Substance Abuse: Research and Treatment, 2012 Bupropion's (Zyban ® SR) effectiveness to treat symptoms experienced in marihuana withdrawal was tested in a double-blind, placebo-controlled study with chronic, heavy marihuana users.
David M. Penetar +4 more
doaj +1 more source
The Lancet Regional Health. EuropeSummary: Background: Alcohol use disorder (AUD) is associated with an enormous burden of disease and cost to society. The dopamine deficiency hypothesis posits that negative reinforcement generated by a low brain dopamine state drives ethanol intake ...
Bo Söderpalm +10 more
doaj +1 more source
Journal of Mazandaran University of Medical Sciences, 2019 Background and purpose: Decreasing the quality of life in cancer patients is an essential factor that influences their lives during the process of treatment and after that.
Saeid Azimi +6 more
doaj
Patient Preference and Adherence, 2016 Cenk Tek Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Abstract: Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain.
Tek C
doaj
The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?
Basic and Clinical Neuroscience, 2019 Introduction: Antidepressants can modulate brain monoamines by acting on pre-synaptic and postsynaptic receptors. Autoreceptors can reduce the monoamines effect on the somatodendritic or pre-synaptic regions despite its postsynaptic counter effects.
Shirin Sadighparvar +4 more
doaj